Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2

Background Atrial fibrillation (AF) is the most common and progressive tachyarrhythmia. Diabetes is a common risk factor for AF. Recent research findings revealed that microtubule network disruption underlies AF. The microtubule network mediates the contact between sarcoplasmic reticulum and mitocho...

Full description

Bibliographic Details
Main Authors: Jin Li, Xi Qi, Kennedy S. Ramos, Eva Lanters, Jaap Keijer, Natasja de Groot, Bianca Brundel, Deli Zhang
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.024478
_version_ 1797857446069272576
author Jin Li
Xi Qi
Kennedy S. Ramos
Eva Lanters
Jaap Keijer
Natasja de Groot
Bianca Brundel
Deli Zhang
author_facet Jin Li
Xi Qi
Kennedy S. Ramos
Eva Lanters
Jaap Keijer
Natasja de Groot
Bianca Brundel
Deli Zhang
author_sort Jin Li
collection DOAJ
description Background Atrial fibrillation (AF) is the most common and progressive tachyarrhythmia. Diabetes is a common risk factor for AF. Recent research findings revealed that microtubule network disruption underlies AF. The microtubule network mediates the contact between sarcoplasmic reticulum and mitochondria, 2 essential organelles for normal cardiomyocyte function. Therefore, disruption of the microtubule network may impair sarcoplasmic reticulum and mitochondrial contacts (SRMCs) and subsequently cardiomyocyte function. The current study aims to determine whether microtubule‐mediated SRMCs disruption underlies diabetes‐associated AF. Methods and Results Tachypacing (mimicking AF) and high glucose (mimicking diabetes) significantly impaired contractile function in HL‐1 cardiomyocytes (loss of calcium transient) and Drosophila (reduced heart rate and increased arrhythmia), both of which were prevented by microtubule stabilizers. Furthermore, both tachypacing and high glucose significantly reduced SRMCs and the key SRMC tether protein mitofusin 2 (MFN2) and resulted in consequent mitochondrial dysfunction, all of which were prevented by microtubule stabilizers. In line with pharmacological interventions with microtubule stabilizers, cardiac‐specific knockdown of MFN2 induced arrhythmia in Drosophila and overexpression of MFN2 prevented tachypacing‐ and high glucose–induced contractile dysfunction in HL‐1 cardiomyocytes and/or Drosophila. Consistently, SRMCs/MFN2 levels were significantly reduced in right atrial appendages of patients with persistent AF compared with control patients, which was aggravated in patients with diabetes. Conclusions SRMCs may play a critical role in clinical AF, especially diabetes‐related AF. Furthermore, SRMCs can be regulated by microtubules and MFN2, which represent novel potential therapeutic targets for AF.
first_indexed 2024-04-09T20:56:50Z
format Article
id doaj.art-cb4959ea7d86455c970c4b1e54c50114
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-09T20:56:50Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-cb4959ea7d86455c970c4b1e54c501142023-03-29T18:35:57ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-10-01111910.1161/JAHA.121.024478Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2Jin Li0Xi Qi1Kennedy S. Ramos2Eva Lanters3Jaap Keijer4Natasja de Groot5Bianca Brundel6Deli Zhang7Department of Physiology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The NetherlandsHuman and Animal Physiology Wageningen University Wageningen The NetherlandsDepartment of Physiology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The NetherlandsDepartment of Cardiology Erasmus Medical Center Rotterdam The NetherlandsHuman and Animal Physiology Wageningen University Wageningen The NetherlandsDepartment of Cardiology Erasmus Medical Center Rotterdam The NetherlandsDepartment of Physiology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The NetherlandsDepartment of Physiology Amsterdam UMC location Vrije Universiteit Amsterdam Amsterdam The NetherlandsBackground Atrial fibrillation (AF) is the most common and progressive tachyarrhythmia. Diabetes is a common risk factor for AF. Recent research findings revealed that microtubule network disruption underlies AF. The microtubule network mediates the contact between sarcoplasmic reticulum and mitochondria, 2 essential organelles for normal cardiomyocyte function. Therefore, disruption of the microtubule network may impair sarcoplasmic reticulum and mitochondrial contacts (SRMCs) and subsequently cardiomyocyte function. The current study aims to determine whether microtubule‐mediated SRMCs disruption underlies diabetes‐associated AF. Methods and Results Tachypacing (mimicking AF) and high glucose (mimicking diabetes) significantly impaired contractile function in HL‐1 cardiomyocytes (loss of calcium transient) and Drosophila (reduced heart rate and increased arrhythmia), both of which were prevented by microtubule stabilizers. Furthermore, both tachypacing and high glucose significantly reduced SRMCs and the key SRMC tether protein mitofusin 2 (MFN2) and resulted in consequent mitochondrial dysfunction, all of which were prevented by microtubule stabilizers. In line with pharmacological interventions with microtubule stabilizers, cardiac‐specific knockdown of MFN2 induced arrhythmia in Drosophila and overexpression of MFN2 prevented tachypacing‐ and high glucose–induced contractile dysfunction in HL‐1 cardiomyocytes and/or Drosophila. Consistently, SRMCs/MFN2 levels were significantly reduced in right atrial appendages of patients with persistent AF compared with control patients, which was aggravated in patients with diabetes. Conclusions SRMCs may play a critical role in clinical AF, especially diabetes‐related AF. Furthermore, SRMCs can be regulated by microtubules and MFN2, which represent novel potential therapeutic targets for AF.https://www.ahajournals.org/doi/10.1161/JAHA.121.024478atrial fibrillationdiabetesDrosophilamicrotubulesmitosusin 2sarcoplasmic reticulum‐mitochondrial contacts
spellingShingle Jin Li
Xi Qi
Kennedy S. Ramos
Eva Lanters
Jaap Keijer
Natasja de Groot
Bianca Brundel
Deli Zhang
Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atrial fibrillation
diabetes
Drosophila
microtubules
mitosusin 2
sarcoplasmic reticulum‐mitochondrial contacts
title Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
title_full Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
title_fullStr Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
title_full_unstemmed Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
title_short Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
title_sort disruption of sarcoplasmic reticulum mitochondrial contacts underlies contractile dysfunction in experimental and human atrial fibrillation a key role of mitofusin 2
topic atrial fibrillation
diabetes
Drosophila
microtubules
mitosusin 2
sarcoplasmic reticulum‐mitochondrial contacts
url https://www.ahajournals.org/doi/10.1161/JAHA.121.024478
work_keys_str_mv AT jinli disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT xiqi disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT kennedysramos disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT evalanters disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT jaapkeijer disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT natasjadegroot disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT biancabrundel disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2
AT delizhang disruptionofsarcoplasmicreticulummitochondrialcontactsunderliescontractiledysfunctioninexperimentalandhumanatrialfibrillationakeyroleofmitofusin2